DOJ Settlement Agreements: Civil and Criminal Resolutions

Settlement agreements reached by the Department of Justice represent legally binding resolutions that close civil and criminal matters without full trials. These instruments span a wide range of enforcement contexts — from healthcare fraud to antitrust violations — and carry significant financial, operational, and reputational consequences for the parties involved. Understanding how settlements are structured, when each type applies, and where the government's decision boundaries lie is essential for anyone navigating federal enforcement.

Definition and scope

A DOJ settlement agreement is a negotiated resolution between the United States government and a private party, corporate entity, or state actor that ends or avoids litigation in exchange for agreed-upon terms. The Department enters settlements in both civil and criminal contexts, and the governing legal framework differs substantially between those two tracks.

On the civil side, the Department's Civil Division handles matters under statutes including the False Claims Act (31 U.S.C. §§ 3729–3733), the Financial Institutions Reform, Recovery, and Enforcement Act (FIRREA), and various consumer protection laws. Civil settlements typically require monetary payment — often including penalties, disgorgement, and restitution — but do not result in criminal conviction or incarceration.

On the criminal side, settlements take the form of plea agreements, deferred prosecution agreements (DPAs), or non-prosecution agreements (NPAs). Each carries distinct legal weight. A plea agreement results in a criminal conviction and is entered before a federal judge, who retains authority to accept or reject its terms. A DPA or NPA, by contrast, allows prosecution to be suspended or avoided entirely if the defendant meets compliance conditions over a defined period, typically 12 to 36 months.

The scope of settlement authority is broad. U.S. Attorneys' Offices across all 94 federal districts can negotiate settlements within their jurisdiction, while Main Justice components — including the Criminal Division, Antitrust Division, and Civil Rights Division — retain authority over nationally significant matters.

How it works

The settlement process follows a structured sequence, though timelines vary widely by case complexity.

1. Investigation and development of evidence. Federal investigators from the FBI, IRS Criminal Investigation, HHS-OIG, or other agencies develop a factual record. Civil Investigative Demands (CIDs) may be issued under the False Claims Act to compel document production before litigation begins.
2. Pre-litigation or pre-indictment negotiation. DOJ attorneys present findings to the target and open settlement discussions. In corporate matters, the DOJ Corporate Enforcement Policy — updated by the Deputy Attorney General's office — governs credit for voluntary disclosure and cooperation.
3. Drafting and internal approval. Settlement terms are memorialized in a written agreement. Civil settlements above a threshold set by internal DOJ guidelines require approval from Main Justice components. Criminal resolutions involving DPAs for corporations require approval from the Deputy Attorney General (28 C.F.R. § 0.15).
4. Execution and court filing. Civil settlements under the False Claims Act must be filed in federal court and are subject to a 60-day government review period under 31 U.S.C. § 3730(b)(1) if the matter originated as a qui tam whistleblower suit. Plea agreements are entered on the record before a district judge.
5. Compliance monitoring. Many agreements — particularly DPAs and consent decrees — require ongoing compliance reporting to DOJ or an independent monitor. The Office of the Deputy Attorney General publishes guidance on monitor selection (DOJ Guidance on Selection of Monitors, 2021).

Common scenarios

DOJ settlement agreements arise across a concentrated set of enforcement areas:

• Healthcare fraud. The False Claims Act enforcement program consistently produces the largest settlement volumes by dollar value. In fiscal year 2023, DOJ recovered over $2.68 billion in False Claims Act settlements and judgments, the majority from healthcare matters (DOJ Press Release, Feb. 22, 2024).
• Foreign bribery and corruption. The Foreign Corrupt Practices Act (FCPA) program routinely resolves through DPAs and NPAs, often in coordinated multi-agency resolutions with the Securities and Exchange Commission.
• Antitrust. Civil antitrust settlements frequently take the form of consent decrees requiring divestitures or behavioral remedies. The Antitrust Division files these in U.S. District Court under the Antitrust Procedures and Penalties Act, 15 U.S.C. § 16.
• Environmental violations. The Environment and Natural Resources Division resolves matters under the Clean Water Act and Clean Air Act through civil judicial settlements that include injunctive relief and civil penalties.
• Civil rights and police reform. The Civil Rights Division resolves pattern-or-practice investigations against law enforcement agencies through consent decrees that impose structural reforms and court supervision.

Decision boundaries

The government's choice between settlement types — civil versus criminal, plea versus DPA — is not arbitrary. Several factors define where the line falls.

Civil vs. criminal threshold. The same underlying conduct can generate civil liability, criminal liability, or both. The central distinction is proof of intent. Criminal prosecution under statutes such as 18 U.S.C. § 1347 (healthcare fraud) requires proof beyond a reasonable doubt that the defendant acted knowingly and willfully. Civil liability under the False Claims Act requires only proof by a preponderance of the evidence, and knowingly includes acts in reckless disregard of the truth (31 U.S.C. § 3729(b)(1)(A)).

Plea agreement vs. DPA/NPA for corporations. Under principles articulated in the DOJ's Corporate Enforcement Policy and the Filip Factors memorandum (now codified in Justice Manual § 9-28.000), prosecutors weigh the nature and seriousness of the offense, the entity's history of misconduct, the adequacy of the proposed compliance program, and the collateral consequences of a criminal conviction — including workforce impact and market disruption — when deciding whether a DPA or outright guilty plea is appropriate.

Individual vs. entity resolution. DOJ policy, restated in the Yates Memorandum (September 9, 2015) and its successors in the Justice Manual, requires that any corporate settlement address individual accountability. A corporate settlement alone does not foreclose — and does not grant immunity to — individual executives absent explicit NPA terms covering named individuals.

An overview of how these resolution mechanisms fit within DOJ's broader prosecutorial framework is available on the DOJ Authority site's index, which maps the Department's enforcement architecture across divisions and programs.